KESIMPTA

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 0078-1007
  • Package NDC 0078-1007-68
  • Package NDC 0078-1007-98
  • Application number BLA125326
  • SPL ID ab75831e-d802-456a-bae6-7c85ef8dc3ed
  • SPL set ID 6a8a3f53-2062-48ff-9dbe-b939df133ca3
  • UNII M95KG522R0
  • RxCUI 2390949
  • RxCUI 2390954

What the source publishes

Labeler
Novartis Pharmaceuticals Corporation
Active ingredients
ofatumumab
Form
INJECTION, SOLUTION
Routes
SUBCUTANEOUS
Administrative status
present-in-source-snapshot
Marketing status
BLA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:0078-1007_ab75831e-d802-456a-bae6-7c85ef8dc3ed
{
  "name": "KESIMPTA",
  "splId": "ab75831e-d802-456a-bae6-7c85ef8dc3ed",
  "labels": [
    {
      "setId": "6a8a3f53-2062-48ff-9dbe-b939df133ca3",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6a8a3f53-2062-48ff-9dbe-b939df133ca3",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=6a8a3f53-2062-48ff-9dbe-b939df133ca3"
    }
  ],
  "routes": [
    "SUBCUTANEOUS"
  ],
  "labeler": "Novartis Pharmaceuticals Corporation",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "1 SYRINGE, GLASS in 1 CARTON (0078-1007-68)  / .4 mL in 1 SYRINGE, GLASS",
      "package_ndc": "0078-1007-68",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20200820"
    },
    {
      "sample": true,
      "description": "1 SYRINGE, GLASS in 1 CARTON (0078-1007-98)  / .4 mL in 1 SYRINGE, GLASS",
      "package_ndc": "0078-1007-98",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20200820"
    }
  ],
  "productId": "0078-1007_ab75831e-d802-456a-bae6-7c85ef8dc3ed",
  "useDomain": "unknown",
  "dosageForm": "INJECTION, SOLUTION",
  "productNdc": "0078-1007",
  "deaSchedule": null,
  "genericName": "ofatumumab",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "OFATUMUMAB",
      "strength": "20 mg/.4mL"
    }
  ],
  "applicationNumber": "BLA125326",
  "marketingCategory": "BLA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20091026",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000175657",
      "N0000175078"
    ],
    "unii": [
      "M95KG522R0"
    ],
    "rxcui": [
      "2390949",
      "2390954"
    ],
    "spl_set_id": [
      "6a8a3f53-2062-48ff-9dbe-b939df133ca3"
    ],
    "pharm_class_epc": [
      "CD20-directed Cytolytic Antibody [EPC]"
    ],
    "pharm_class_moa": [
      "CD20-directed Antibody Interactions [MoA]"
    ],
    "manufacturer_name": [
      "Novartis Pharmaceuticals Corporation"
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:0078-1007_ab75831e-d802-456a-bae6-7c85ef8dc3ed"